SCHEMBL8008615

SCHEMBL8008615

CCc1ccccc1NC=C1C(=O)N(c2ccc(NC(=O)OC)cc2)N=C1C(CC)C(=O)O

nearest known ligand 0.35

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.35
MEN1 O00255 4/20 0.35
ALDH1A1 P00352 4/20 0.35
MAPT P10636 2/20 0.35
GAA P10253 1/20 0.35
PKM P14618 1/20 0.35
HPGD P15428 2/20 0.34
KAT8 Q9H7Z6 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.33
RAB9A P51151 2/20 0.33
KCNQ2 O43526 1/20 0.33
NPC1 O15118 1/20 0.33
HTT P42858 1/20 0.33
CMA1 P23946 1/20 0.33
CRHBP P24387 1/20 0.32
CRHR2 Q13324 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
POLB P06746 1/20 0.32
F11 P03951 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8008968 0.93 HPGD (0.39) KMT2AMEN1ALDH1A1MAPTGAA
SCHEMBL8011512 0.91 MEN1 (0.39) KMT2AMEN1ALDH1A1MAPTGAA
SCHEMBL7999795 0.88 TP53 (0.38) KMT2AMEN1ALDH1A1GAAKAT8
SCHEMBL8008606 0.86 KDM4E (0.35) KMT2AMEN1ALDH1A1MAPTHPGD
SCHEMBL8009344 0.84 MAPT (0.43) KMT2AMEN1ALDH1A1MAPTGAA
SCHEMBL8427443 0.84 ALDH1A1 (0.33) KMT2AMEN1ALDH1A1MAPTGAA
SCHEMBL6944940 0.83 ALDH1A1 (0.43) KMT2AMEN1ALDH1A1MAPTGAA
SCHEMBL6944935 0.83 ALDH1A1 (0.43) KMT2AMEN1ALDH1A1MAPTGAA
SCHEMBL8009329 0.82 SHMT2 (0.37) KMT2AALDH1A1MAPTPKMHPGD
SCHEMBL8008612 0.80 KMT2A (0.37) KMT2AMEN1ALDH1A1MAPTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6034099-A Method for inhibiting neoplastic lesions by administering 4-(arylmethylene)- 2, 3- dihydro-pyrazol-3-ones CELL PATHWAYS, INC. (US) 2000-03-07 US claimed
US-6034099-A Method for inhibiting neoplastic lesions by administering 4-(arylmethylene)- 2, 3- dihydro-pyrazol-3-ones CELL PATHWAYS, INC. (US) 2000-03-07 US disclosed